The anti-apoptotic effect of PD-L1 on cancer cells might result in simultaneous increase of PI3K/Akt activity and elevated rate of tumor-intrinsic glycolysis, both hallmarks of metabolically active, proliferating cancers. The gene discussed is CD274; the disease is cancer.